Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles

被引:14
作者
Ali, Khan Hashim [1 ]
Ansari, Muhammad Mohsin [1 ]
Shah, Fawad Ali [1 ]
Din, Fakhar Ud [2 ]
Basit, Muhammad Abdul [3 ]
Kim, Jin-Ki [4 ]
Zeb, Alam [1 ]
机构
[1] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Sector G-7-4,7th Ave, Islamabad 44000, Pakistan
[2] Quaid I Azam Univ, Dept Pharm, Islamabad, Pakistan
[3] Inst Space Technol, Dept Mat Sci & Engn, Islamabad, Pakistan
[4] Hanyang Univ, Inst Pharmaceut Sci & Technol, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, Gyeonggi, South Korea
关键词
Valsartan; vanillin; co-amorphous system; mesoporous silica particles; dissolution; PHYSICAL STABILITY; SOLUBLE DRUGS; AMINO-ACIDS; PHYSICOCHEMICAL PROPERTIES; COAMORPHOUS ATORVASTATIN; SOLUBILITY; DELIVERY; BIOAVAILABILITY; OPTIMIZATION; INDOMETHACIN;
D O I
10.1080/02652048.2019.1579265
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The study was aimed to prepare a co-amorphous system of valsartan (VAL) with vanillin (VAN) for improving its solubility and dissolution followed by its confinement in mesoporous silica particles (MSPs) to stabilise the co-amorphous system and prevent its recrystallization. Amorphous VAL and VAN were obtained through quench-cooling and VAL/VAN binary co-amorphous system (VAL/VAN-CAS) was prepared through solvent evaporation technique. The particle size and morphology of VAL/VAN-CAS-MSPs were studied using scanning electron microscopy (SEM) and solid-state characterisation was performed by differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). The in vitro dissolution was investigated by dialysis bag diffusion method. SEM analysis revealed irregular shaped VAL/VAN-CAS-MSPs with a size range of 5-25m, while outcomes of DSC and XRPD confirmed the formation of VAL/VAN-CAS. The in vitro dissolution profiles demonstrated a significantly increased dissolution in first 60minutes from VAL/VAN-CAS (approximate to 68%) and VAL/VAN-CAS-MSPs (approximate to 76%) compared to powder VAL (approximate to 25%).
引用
收藏
页码:10 / 20
页数:11
相关论文
共 55 条
  • [1] Enhancement of in vitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS
    Ahsan M.N.
    Verma P.R.P.
    [J]. Journal of Pharmaceutical Investigation, 2018, 48 (3) : 269 - 278
  • [2] Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation
    Alleso, Morten
    Chieng, Norman
    Rehder, Soenke
    Rantanen, Jukka
    Rades, Thomas
    Aaltonen, Jaakko
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 136 (01) : 45 - 53
  • [3] Development, Optimization, and Characterization of Solid Self-Nanoemulsifying Drug Delivery Systems of Valsartan Using Porous Carriers
    Beg, Sarwar
    Swain, Suryakanta
    Singh, Harendra Pratap
    Patra, Ch Niranjan
    Rao, M. E. Bhanoji
    [J]. AAPS PHARMSCITECH, 2012, 13 (04): : 1416 - 1427
  • [4] The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State
    Bi, Yanping
    Xiao, Deli
    Ren, Shuai
    Bi, Shuyan
    Wang, Jianzhu
    Li, Fei
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (10) : 3150 - 3155
  • [5] Facile large-scale preparation of mesoporous silica microspheres with the assistance of sucrose and their drug loading and releasing properties
    Bi, Yanping
    Wu, Chaonan
    Xin, Ming
    Bi, Shuyan
    Yan, Chengxin
    Hao, Jifu
    Li, Fei
    Li, Shou
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 500 (1-2) : 77 - 84
  • [6] Improvement of solubility and stability of valsartan by hydroxypropyl-β-cyclodextrin
    Cappello, Brunella
    Di Maio, Clelia
    Iervolino, Maria
    Miro, Agnese
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2006, 54 (3-4) : 289 - 294
  • [7] Co amorphous systems: A product development perspective
    Chavan, Rahul B.
    Thipparaboina, Rajesh
    Kumar, Dinesh
    Shastri, Nalini R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) : 403 - 415
  • [8] Chavda H.V., 2010, Syst. Rev. Pharm, V1, P62, DOI DOI 10.4103/0975-8453.59514
  • [9] Differential scanning calorimetry: applications in drug development
    Clas, SD
    Dalton, CR
    Hancock, BC
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (08): : 311 - 320
  • [10] Dash S, 2010, ACTA POL PHARM, V67, P217